HUGE
Price:
$0.0899
Market Cap:
$66.67K
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-06-08
Stock Exchange
NASDAQ
Ticker
HUGE
According to FSD Pharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -100.00% compared to the average of -337.66 of the last 4 quarters.
The mean historical PE Ratio of FSD Pharma Inc. over the last ten years is -69806.63. The current -0.01 PE Ratio has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), HUGE's PE Ratio was at its highest in in the September 2018 quarter at 4.95K. The PE Ratio was at its lowest in in the March 2017 quarter at -26516388.05.
Average
-69806.63
Median
-127.50
Minimum
-327011.17
Maximum
-37.33
Discovering the peaks and valleys of FSD Pharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 75.32%
Maximum Annual PE Ratio = -37.33
Minimum Annual Increase = -98.99%
Minimum Annual PE Ratio = -327011.17
Year | PE Ratio | Change |
---|---|---|
2023 | -127.50 | 49.80% |
2022 | -85.11 | 30.07% |
2021 | -65.44 | 75.32% |
2020 | -37.33 | -53.72% |
2019 | -80.66 | -94.03% |
2018 | -1350.61 | -59.30% |
2017 | -3318.83 | -98.99% |
2016 | -327011.17 | 10.41% |
The current PE Ratio of FSD Pharma Inc. (HUGE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-92.68
5-year avg
-79.21
10-year avg
-69806.63
FSD Pharma Inc.’s PE Ratio is less than RAMM Pharma Corp. (0), less than Craftport Cannabis Corp. (-0.01), less than Speakeasy Cannabis Club Ltd. (-0.00), greater than City View Green Holdings Inc. (-1.11), less than RavenQuest BioMed Inc. (-0.00), greater than China SXT Pharmaceuticals, Inc. (-0.02), greater than Biofrontera Inc. (-0.42), less than Acorda Therapeutics, Inc. (-0.00), greater than Lucy Scientific Discovery Inc. (-0.72), greater than Link Reservations Inc. (-2.96), less than MERCK Kommanditgesellschaft auf Aktien (27.77), greater than SOHM, Inc. (-5.35), greater than The Greater Cannabis Company, Inc. (-2.76), greater than Global Hemp Group Inc. (-0.20), greater than SLANG Worldwide Inc. (-0.09), less than American Green, Inc. (0), greater than Medical Marijuana, Inc. (-0.29), greater than Cannara Biotech Inc. (-1.23), less than Green Cures & Botanical Distribution Inc. (13.33), less than Cann American Corp. (1.21), less than Rimrock Gold Corp. (0.39), greater than Galexxy Holdings, Inc. (-35.51), greater than Indoor Harvest Corp (-6.04), greater than null (-0.11),
Company | PE Ratio | Market cap |
---|---|---|
0 | $15.16M | |
-0.01 | $2.01M | |
-0.00 | $1.31K | |
-1.11 | $1.42M | |
-0.00 | $482.11K | |
-0.02 | $1.99M | |
-0.42 | $6.15M | |
-0.00 | $821.03K | |
-0.72 | $906.91K | |
-2.96 | $1.89M | |
27.77 | $80.87B | |
-5.35 | $2.05M | |
-2.76 | $523.01K | |
-0.20 | $442.11K | |
-0.09 | $1.25M | |
0 | $666.29K | |
-0.29 | $5.69M | |
-1.23 | $52.21M | |
13.33 | $522.63K | |
1.21 | $1.26M | |
0.39 | $312.30K | |
-35.51 | $5.16M | |
-6.04 | $310.57K | |
-0.11 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like FSD Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like FSD Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is FSD Pharma Inc.'s PE Ratio?
How is the PE Ratio calculated for FSD Pharma Inc. (HUGE)?
What is the highest PE Ratio for FSD Pharma Inc. (HUGE)?
What is the 3-year average PE Ratio for FSD Pharma Inc. (HUGE)?
What is the 5-year average PE Ratio for FSD Pharma Inc. (HUGE)?
How does the current PE Ratio for FSD Pharma Inc. (HUGE) compare to its historical average?